Announcements Trials

Browse Landscape

Status

Unknown 10 Completed 8 Recruiting 5 Not yet recruiting 3 Active not recruiting 3 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 11 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 138 Neoplasms 134 Lung Neoplasms 68 Prostatic Neoplasms 67 Carcinoma, Non-Small-Cell Lung 58 Colorectal Neoplasms 45 Multiple Myeloma 37 Pancreatic Neoplasms 33 Melanoma 32 Head and Neck Neoplasms 30 Brain Neoplasms 30 Neoplasm Metastasis 28 Ovarian Neoplasms 27 Liver Neoplasms 27 Carcinoma, Hepatocellular 27 Leukemia, Myeloid, Acute 25 Colonic Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Esophageal Neoplasms 20 Carcinoma, Renal Cell 20 Lymphoma, Non-Hodgkin 19 Urinary Bladder Neoplasms 18 Stomach Neoplasms 18 Glioblastoma 18 Uterine Cervical Neoplasms 17 Sarcoma 17 Lymphoma, Follicular 17 Lymphoma, Large B-Cell, Diffuse 16

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observational × NSCLC × Clear all

NCT04557007 2026-01-29

Oncomabs

Oslo University Hospital

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡